NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









RemeGen

RemeGen

Public
Yantai, ShandongHealthcarehttps://remegen.com/

RemeGen is now publicly traded

The data on this page reflects RemeGen's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Nov 9, 2020

Last Round

Follow-on Offering

Mar 31, 2022

Total Funding Raised

$1.03B

Company Overview

RemeGen is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative biologic drugs for the treatment of autoimmune, oncology, and ophthalmic diseases.

Sector

Healthcare

AI Layer

Application

Keywords

biopharmaceuticalbiotechantibody-drug conjugateADCfusion proteinautoimmune disease treatmentoncologydrug discoveryclinical trialsbiologicsprotein engineeringpharma licensingAI-driven drug discoveryin-silico drug design

RemeGen Comparables

Compare RemeGen with similar companies based on industry and business-model similarity.

RemeGen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

RemeGen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Follow-on OfferingMar 31, 2022
IPONov 9, 2020
Private EquityMar 16, 2020

RemeGen Investors

Notable investors and investment history

RemeGen investors
InvestorRounds
Loyal Valley CapitalPrivate Equity
Lake Bleu CapitalIPO, Private Equity
Huatai InternationalIPO
Hillhouse Capital GroupIPO
OrbiMedPrivate Equity, IPO
Morgan StanleyIPO
Janchor PartnersPrivate Equity

RemeGen Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RemeGen Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersYantai, Shandong
Employee Range3
Year Founded2008
Last FundingMar 31, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.